Effects of COVID-19 on Intravitreal Injection Clinic After Lockdown
Open Access
- 19 September 2022
- journal article
- research article
- Published by Taylor & Francis in Clinical Ophthalmology
- Vol. ume 16, 3089-3096
Abstract
Purpose: To examine the return of patients to intravitreal injection clinic after the COVID-19 lockdown. Patients and Methods: The electronic medical records of all patients who received intravitreal injections at a tertiary care Veterans Health Administration (VHA) clinic 14 weeks post-lockdown (5/9/20-8/13/20) in Los Angeles County were reviewed. Reference groups included injection patients during the 7-week COVID-19 lockdown (3/19/20-5/8/20) and a 7-week pre-pandemic period in 2019 (3/19/19-5/8/19). Clinic volume was compared using a one-way ANOVA. Demographic data, medical and psychiatric co-morbidities, injection diagnoses, visual acuities, and clinic volumes were compared between the 3 periods using a generalized estimating equation multivariate analysis. Results: The post-lockdown period group averaged 25.1 visits per week, compared with 12.3/week during lockdown and 25.4/week pre-COVID in intravitreal injection clinic. In the post-lockdown period, the VHA injection clinic returned closer to the pre-lockdown volume compared to the VHA comprehensive clinic (98.9% vs 57.4%, p < 0.001). Post-lockdown, COPD patients and organ transplant patients were less likely to receive injections compared to 2019 (OR 0.76 p = 0.008, OR 1.37 p < 0.0001, respectively). Patients with a diagnosis of cancer increased in proportion between the pre-pandemic and the post-lockdown periods (OR 1.31, p = 0.007). No differences were found, according to psychiatric co-morbidities. After lockdown, the proportion of patients receiving injections for diabetic macular edema (DME) increased (OR 1.11, p = 0.01). Conclusion: Injection volume returned to pre-pandemic levels immediately after lockdown ended. However, patients with high-risk comorbidities did not return to intravitreal injection clinic post-lockdown. These results can inform medical organizations, which groups may need increased safety measures and targeted outreach to address their ophthalmic needs.Keywords
This publication has 35 references indexed in Scilit:
- Use of Telehealth by Surgical Specialties During the COVID-19 PandemicJAMA Surgery, 2021
- Anti-VEGF intravitreal injections in the era of COVID-19: responding to different levels of epidemic pressureGraefe's Archive for Clinical and Experimental Ophthalmology, 2021
- Impact of COVID-19 pandemic on mental health in the general population: A systematic reviewJournal of Affective Disorders, 2020
- Short-term outcomes of patients with neovascular exudative AMD: the effect of COVID-19 pandemicGraefe's Archive for Clinical and Experimental Ophthalmology, 2020
- Visit adherence and visual acuity outcomes in patients with diabetic macular edema: a secondary analysis of DRCRnet Protocol TGraefe's Archive for Clinical and Experimental Ophthalmology, 2020
- Impact of COVID-19 on outpatient visits and intravitreal treatments in a referral retina unit: let’s be ready for a plausible “rebound effect”Graefe's Archive for Clinical and Experimental Ophthalmology, 2020
- Is virtual existence our new reality?Graefe's Archive for Clinical and Experimental Ophthalmology, 2020
- Effect of Initial Management With Aflibercept vs Laser Photocoagulation vs Observation on Vision Loss Among Patients With Diabetic Macular Edema Involving the Center of the Macula and Good Visual AcuityJAMA, 2019
- High HDL cholesterol: A risk factor for diabetic retinopathy? Findings from NO BLIND studyDiabetes Research and Clinical Practice, 2019
- Health and Health Behavior DifferencesAmerican Journal of Preventive Medicine, 2012